To Evaluate the Safety and Efficacy of Human BCMA Targeted CAR-NK Cells Injection for Subjects With R/R MM or PCL
Clinical trial NCT06045091 · RECRUITING
Trial details
- NCT number
- NCT06045091
- Sponsor
- Hrain Biotechnology Co., Ltd.
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-04
- Primary completion
- 2025-09-30
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.